Stockscreener 앱 받기
0.868
3.27%
-0.0293
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences - Moomoo
- SEC.gov
Standard BioTools (LAB) plans sale of Mass Cytometry business alongside Treeline deal - Stock Titan
Standard BioTools sells mass cytometry unit, gets $30M buyout - Investing.com
Standard BioTools (NASDAQ: LAB) nets $30M Illumina buyout, sells mass cytometry arm - Stock Titan
Standard BiotoolsEnters Termination, Waiver And Release Agreement With Illumina On July 24, 2026SEC Filing - TradingView
Standard BioTools Sells Mass Cytometry Unit for $5 Million Note and Nets $30 Million From Illumina - TradingView
Standard BioTools Announces Sale of Mass Cytometry Business - GlobeNewswire
Standard BioTools Inc (LAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Form 4 Standard Biotools Inc For: 27 July By Investing.com - Investing.com Canada
Standard BioTools Inc. (LAB) CFO share withholding for tax obligations - Stock Titan
Standard BioTools Inc. Revenue Breakdown – GETTEX:FLB - TradingView
Standard BioTools Inc (LAB) Income Statement - TradingKey
LAB|Standard BioTools Inc|Price:0.833|Chg%:-0.042 - TradingKey
Standard BioTools Inc (LAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Standard BioTools Inc (LAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Standard BioTools Inc (LAB) Institutional Confidence - TradingKey
Standard BioTools Inc (LAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Standard BioTools Inc (LAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Standard BioTools Inc (LAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Standard BioTools Inc (LAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
LAB|Standard BioTools Inc|Price:0.802|Chg%:-0.031 - TradingKey
Standard BioTools Receives Nasdaq Bid Price Deficiency Notice - TipRanks
Standard BioTools Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Standard BioTools (NASDAQ: LAB) warned on Nasdaq minimum bid-price compliance - Stock Titan
Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rule - Bitget
Standard BioTools Inc (LAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026 - Investing News Network
Standard BioTools will post its next update after market close Aug. 5 - Stock Titan
Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? - TradingView
Standard BioTools files merger registration with Treeline By Investing.com - Investing.com South Africa
Standard BioTools (LAB) details Treeline merger, $900M cash and TLN-121 data - Stock Titan
Standard BioTools files merger registration with Treeline - Investing.com
Standard BioTools Files S-4 for Merger with Treeline Biosciences, Highlighting Promising TLN-121 Clinical Data and Strong Cash Position - Quiver Quantitative
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction - GlobeNewswire
Standard BioTools (NASDAQ: LAB) outlines all-stock Treeline Biosciences merger and CVR plan - Stock Titan
Standard Biotools Inc (FLB) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Standard BioTools (LAB) reports Q1 loss, tops revenue estimates - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB - Sahm
Standard BioTools (LAB) Rallies 4.4% After Support Test – Key Resistance in SightETF Creation Redemption - dars.gov.et
FLDM4094699 Bond Profile — Key Metrics - TradingView
FLDM4094699 Bond Redemption Profile - TradingView
Standard Biotools Inc (FLB) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Standard Biotools Inc (FLB) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Standard BioTools (LAB) Holds Above Key Support After Modest UptickBuffered ETF - dars.gov.et
Standard BioTools (LAB) Slides to $0.92 – Support Test in FocusInverse ETF Flow - dars.gov.et
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders - AOL.com
Standard BioTools (LAB) Surges Over 5%, Nears Key Resistance at $0.96RTH Profile - dars.gov.et
Standard BioTools Inc. (LAB) Surges 5% as Stock Approaches Key Resistance LevelOvernight Profile - dars.gov.et
Standard BioTools (LAB) Surges 5.36% as Shares Test Key Resistance LevelWave Truncation - dars.gov.et
Standard BioTools Q1 2026 Earnings: Massive EPS Beat Turns Loss Estimate into ProfitEarnings Outlook Update - DonanımHaber
Standard BioTools Inc. (LAB) Q1 2026 Earnings: EPS Surges 800% Above Estimates, Stock Edges LowerWeak Earnings Momentum - dars.gov.et
Standard BioTools Inc. (LAB) Q1 2026 Earnings: EPS Surges 800% Above Estimates Amid Revenue Uncertainty - dars.gov.et
Enterprise value to revenue forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to earnings forward of Standard BioTools Inc. – BOATS:LAB - TradingView
Enterprise value to EBITDA forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to book forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to sales forward of Standard BioTools Inc. – BOATS:LAB - TradingView
Form 4 Standard Biotools Inc For: 23 June - Investing.com UK
Form 4 Standard Biotools Inc For: 23 June By Investing.com - Investing.com Australia
1.04%
11.95%
자본화:
|
볼륨(24시간):